1887

Journal of General Virology header logo

Volume 80, Issue 4

The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon. Free

Abstract

The non-structural protein 5A (NS5A) of some hepatitis C virus (HCV) isolates has been implicated in the inhibition of the antiviral activity of interferon (IFN). In the present study, the possible inhibitory effects of NS5A from two isolates of HCV subtype 1b, HCV-1bJk and M094AJk, and their chimeric form on the antiviral activity of IFN were examined. HCV-1bJk and M094AJk are categorized as IFN resistant and IFN sensitive, respectively, based on the sequences of the IFN-sensitivity determining region (ISDR). When encephalomyocarditis virus was used as a challenge virus, NS5A was shown to eliminate the antiviral activity of IFN, with inhibition being more prominent with HCV-1bJk NS5A than with M094AJk NS5A. Moreover, the inhibition was significantly weaker in cells expressing a chimeric NS5A that had a short stretch of 49 amino acids (aa 2209-2257), including the ISDR sequence, from M094AJk in the backbone of the HCV-1bJk sequence than in cells expressing the original NS5A from HCV-1bJk. These results suggest an important role for the 49 aa sequence, including the ISDR, in the inhibition of IFN-mediated antiviral activity. On the other hand, only a slight reduction of IFN antiviral activity by HCV-1bJk NS5A was observed when vesicular stomatitis virus was used as a challenge virus, and barely any reduction was observed when Japanese encephalitis virus was used. These results may reflect differential importance of each of the IFN-mediated signalling pathways in conferring resistance against different viruses.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1999
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-4-879
1999-04-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/4/0800879a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-4-879&mimeType=html&fmt=ahah

References

  1. Apichartpiyakul C., Chittivudikarn C., Miyajima H., Homma M., Hotta H. 1994; Analysis of hepatitis C virus isolates among healthy blood donors and drug addicts in Chiang Mai, Thailand. Journal of Clinical Microbiology 32:2276–2279
     [Google Scholar]
  2. Asabe S. I., Tanji Y., Satoh S., Kaneko T., Kimura K., Shimotohno K. 1997; The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent hyperphosphorylation. Journal of Virology 71:790–796
     [Google Scholar]
  3. Chebath J., Benech P., Revel M., Vigneron M. 1987; Constitutive expression of (2′–5′) oligo A synthetase confers resistance to picornavirus infection. Nature 330:587–588
     [Google Scholar]
  4. Coccia E. M., Romeo G., Nissim A., Marziali G., Albertini R., Affabris E., Battistini A., Fiorucci G., Orsatti R., Rossi G. B., Chebath J. 1990; A full-length murine 2–5A synthetase cDNA transfection in NIH-3T3 cells impairs EMCV but not VSV replication. Virology 179:228–233
     [Google Scholar]
  5. Dan K., Seto Y., Fujita T., Asaba Y., Takei I., Fujita H., Kato R. 1995; Characterization of insulin-dependent diabetes mellitus induced by a new variant (DK-27) of encephalomyocarditis virus in DBA/2 mice. Experimental Animals 44:211–218
     [Google Scholar]
  6. Doi H., Apichartpiyakul C., Ohba K., Mizokami M., Hotta H. 1996; Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. Journal of Clinical Microbiology 34:569–574
     [Google Scholar]
  7. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Ogura Y., Izumi N., Marumo F., Sato C. 1996; Mutations in the nonstructural protein NS5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. New England Journal of Medicine 334:77–81
     [Google Scholar]
  8. Gale M. J., Korth M. J. Jr, Tang N. M., Tan S. L., Hopkins D. A., Dever T. E., Polyak S. J., Gretch D. R., Katze M. G. 1997; Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217–227
     [Google Scholar]
  9. Gale M. Jr, Blakely C. M., Kwieciszewski B., Tan S.-L., Dosset M., Tang N. M., Korth M. J., Polyak S. J., Gretch D. R., Katze M. G. 1998; Control of PKR protein kinase by hepatitis C virus nonstructural protein 5A: molecular mechanisms of kinase regulation. Molecular and Cellular Biology 18:5208–5218
     [Google Scholar]
  10. Green S., Issemann I., Sheer E. 1988; A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Research 16:369
     [Google Scholar]
  11. Hassel B. A., Zhou A., Sotomayer C., Maran A., Silverman R. H. 1993; A dominant negative mutant of 2–5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO Journal 12:3297–3304
     [Google Scholar]
  12. Hotta H., Hotta S., Homma M. 1984; Effect of interferons on dengue virus multiplication in cultured monocytes/macrophages. Biken Journal 27:189–193
     [Google Scholar]
  13. Houghton M. 1996; Hepatitis C viruses. In Fields Virology 3rd edn pp 1035–1058 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott-Raven;
     [Google Scholar]
  14. Ide Y., Zhang L., Chen M., Inchauspe G., Bahl C., Sasaguri Y., Padmanabhan R. 1996; Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. Gene 182:203–211
     [Google Scholar]
  15. Kanai K., Kako M., Okamoto H. 1992; HCV genotypes in chronic hepatitis C and response to interferon. Lancet 339:1543
     [Google Scholar]
  16. Kaneko T., Tanji Y., Satoh S., Hijikata M., Asabe S., Kimura K., Shimotohno K. 1994; Production of two phosphoproteins from the NS5A region of the hepatitis C virus genome. Biochemical and Biophysical Research Communications 205:320–326
     [Google Scholar]
  17. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. 1990; Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proceedings of the National Academy of Sciences, USA 87:9524–9528
     [Google Scholar]
  18. Kato N., Lan K. H., Ono-nita S. K., Shiratori Y., Omata M. 1997; Hepatitis C virus nonstructural region 5A is a potent transcriptional activator. Journal of Virology 71:8856–8859
     [Google Scholar]
  19. Li X.-L., Blackford J. A., Hassel B. A. 1998; RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection. Journal of Virology 72:2752–2759
     [Google Scholar]
  20. Lin C., Wu J.-W., Hsiao K., Su M. S.-S. 1997; The hepatitis C virus NS4A protein: interaction with the NS4B and NS5A proteins. Journal of Virology 71:6465–6471
     [Google Scholar]
  21. Manabe S., Fuke I., Tanishita O., Kaji C., Gomi Y., Yoshida S., Mori C., Takamizawa A., Yoshida I., Okayama H. 1994; Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology 198:636–644
     [Google Scholar]
  22. Mellor J., Holmes E. C., Jarvis L. M., Yap P. L., Simmonds P. The International HCV Collaborative Study Group 1995; Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. Journal of General Virology 76:2493–2507
     [Google Scholar]
  23. Muramatsu S., Ishido S., Fujita T., Itoh M., Hotta H. 1997; Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization. Journal of Virology 71:4954–4961
     [Google Scholar]
  24. Pozzato G., Moretti M., Franzin F., Croce L. S., Tiribelli C., Masayu T., Kaneko S., Unoura M., Kobayashi K. 1991; Severity of liver disease with different hepatitis C viral clones. Lancet 338:509
     [Google Scholar]
  25. Reed K. E., Xu J., Rice C. M. 1997; Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase. Journal of Virology 71:7187–7197
     [Google Scholar]
  26. Sen G. C., Ransohoff R. M. 1993; Interferon-induced antiviral action and their regulation. Advances in Virus Research 42:57–102
     [Google Scholar]
  27. Soetjipto J., Handajani R., Lusida M. I., Darmadi S., Adi P., Soemarto , Ishido S., Katayama Y., Hotta H. 1996; Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis, and patients with hepatocellular carcinoma in Surabaya, Indonesia. Journal of Clinical Microbiology 34:2875–2880
     [Google Scholar]
  28. Squadrito G., Leone F., Sartori M., Nalpas B., Berthelot P., Raimondo G., Pol S., Brechot C. 1997; Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. Gastroenterology 113:567–572
     [Google Scholar]
  29. Takehara T., Hayashi N., Miyamoto Y., Yamamoto M., Mita E., Fusamoto H., Kamada T. 1995; Expression of the hepatitis C virus genome in rat liver after cationic liposome-mediated in vivo gene transfer. Hepatology 21:746–751
     [Google Scholar]
  30. Tanimoto A., Ide Y., Arima N., Sasaguri Y., Padmanabhan R. 1997; The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast. Biochemical and Biophysical Research Communications 236:360–364
     [Google Scholar]
  31. Tanji Y., Kaneko T., Satoh S., Shimotohno K. 1995; Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. Journal of Virology 69:3980–3986
     [Google Scholar]
  32. Vilcek J., Sen G. C. 1996; Interferons and other cytokines. In Fields Virology 3rd edn pp 375–399 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
     [Google Scholar]
  33. Zeuzem S., Lee J. H., Roth W. K. 1997; Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology 25740–744
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-4-879
Loading
The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon.
J. Gen. Virol. 80, 879 (1999); https://doi.org/10.1099/0022-1317-80-4-879
/content/journal/jgv/10.1099/0022-1317-80-4-879
/content/journal/jgv/10.1099/0022-1317-80-4-879
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error